author-photo

Sherri Cicero

Celgene

7

Papers

323

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (26)
Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

2013 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study

2012 Blood
Show All
- Source
- Cite
- Save
Citations (17)